Patent ID: 11860162
Assignee: ONCIMMUNE GERMANY GMBH
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 0:
1. A method for detection, diagnosis, differential diagnosis, prognosis, therapy control, or aftercare of systemic lupus erythematosus (SLE), comprising:
a) contacting a panel of markers comprising at least one sequence selected from SEQ ID NO: HNRNPA1 (SEQ ID NO: 1063), MVP (SEQ ID NO: 1065), TMPO (SEQ ID NO: 1076), and ZNF574 (SEQ ID NO: 1082) with a bodily fluid or a tissue sample from an individual to be tested for SLE compared to a healthy control;
b) detecting an interaction of the bodily fluid or tissue sample with at least one of the marker from step a);
c) comparing a relative change of the interaction between the individual and the healthy control; and
d) identifying a SLE patient for stratification and administering at least one therapeutic agent to the SLE patient for treatment.